about
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells.Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients.Interplay between 3'-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans.Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer.Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer.Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cellsPatients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomyRepertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracilPlatelets and inflammatory markers in patients with gastric cancer.Assessment of platelet activation and phagocytic activity in gastric cancer patientsCollaborating with the enemy: function of macrophages in the development of neoplastic disease.Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome.BMI and lymph node ratio may predict clinical outcomes of gastric cancer.Vasohibin-1 and vasohibin-2 expression in gastric cancer cells and TAMs.Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer.Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients.Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
P2860
Q32884377-2EDC7709-FC36-4F95-8D42-19C2F72E7FDCQ34255543-D62E1217-CCAF-4845-94ED-DBDB87805742Q34341453-F066CDD3-1C26-4039-9108-B9ED8B8F0E3AQ34894525-F730DBF6-54A9-403A-A818-FCB4D28E19EEQ35113402-328CBABD-3780-4C05-8D9B-5B7365F42AE9Q36023196-601A11E3-A436-4441-9FBE-E51BA44FE9DAQ36223964-10CE14B3-0503-408F-A809-9A731A64882DQ36559874-9D0CD791-B241-45B2-9657-7A02EAA19A1EQ36646562-B3094465-83B6-49A8-BCF5-A2750797116DQ36649559-76BAD151-1C9B-4BD8-BEC8-60087C4B7B54Q36716346-80B802F1-DF47-4537-9269-F6851F00B0E3Q36770333-0B258F92-FC06-440D-99B7-522EF5D421AEQ38098161-C70FD339-3784-4386-BE11-11FB1F867C6BQ38899446-892B315F-A7EE-4988-83C2-29B404829F83Q39257645-2C6829E3-2315-40E2-A24D-96DA8FACE4FBQ39375805-6F31DC28-A577-4025-A51F-E364A134586EQ39587846-30687BE7-653F-47FE-BB9A-C43DC73D558EQ43471758-14BF6D1F-2A0C-48C7-B585-2FB3A7E72A8BQ44039441-64EBF694-810F-424E-A54D-FB012BBC812CQ58584387-B46C2C45-3E07-44A8-8783-8568156C01EE
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiogenesis and lymphangiogenesis of gastric cancer.
@en
Angiogenesis and lymphangiogenesis of gastric cancer.
@nl
type
label
Angiogenesis and lymphangiogenesis of gastric cancer.
@en
Angiogenesis and lymphangiogenesis of gastric cancer.
@nl
prefLabel
Angiogenesis and lymphangiogenesis of gastric cancer.
@en
Angiogenesis and lymphangiogenesis of gastric cancer.
@nl
P2860
P356
P1433
P1476
Angiogenesis and lymphangiogenesis of gastric cancer.
@en
P2093
Yasuhiko Kitadai
P2860
P304
P356
10.1155/2010/468725
P577
2010-03-29T00:00:00Z